Kathryn Hassell
Concepts (511)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Sickle Cell | 41 | 2023 | 215 | 6.900 |
Why?
| Water Pollutants, Chemical | 13 | 2022 | 175 | 2.430 |
Why?
| Antiphospholipid Syndrome | 5 | 2023 | 26 | 1.920 |
Why?
| Migraine Disorders | 2 | 2023 | 82 | 1.440 |
Why?
| Anticoagulants | 8 | 2021 | 550 | 1.340 |
Why?
| Perciformes | 5 | 2018 | 17 | 1.230 |
Why?
| Heparin | 5 | 2011 | 224 | 1.200 |
Why?
| Thrombocytopenia | 5 | 2014 | 177 | 1.180 |
Why?
| Fishes | 4 | 2021 | 80 | 1.120 |
Why?
| Antibodies, Antiphospholipid | 4 | 2023 | 21 | 1.120 |
Why?
| Estrogens | 3 | 2016 | 312 | 0.880 |
Why?
| Hydroxyurea | 5 | 2016 | 30 | 0.840 |
Why?
| Pyridones | 2 | 2021 | 123 | 0.810 |
Why?
| Blood Transfusion | 7 | 2015 | 293 | 0.760 |
Why?
| Disorders of Sex Development | 2 | 2018 | 35 | 0.740 |
Why?
| Hypertension, Pulmonary | 10 | 2019 | 1727 | 0.740 |
Why?
| Hirudins | 4 | 2011 | 46 | 0.730 |
Why?
| Fibrinolytic Agents | 2 | 2021 | 234 | 0.710 |
Why?
| Hemoglobins | 8 | 2021 | 315 | 0.710 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2023 | 219 | 0.710 |
Why?
| Pyrazoles | 2 | 2021 | 362 | 0.700 |
Why?
| Testis | 2 | 2018 | 133 | 0.700 |
Why?
| Caprylates | 1 | 2020 | 19 | 0.680 |
Why?
| Quality of Life | 6 | 2017 | 2353 | 0.670 |
Why?
| Alkanesulfonic Acids | 1 | 2020 | 28 | 0.670 |
Why?
| Environmental Monitoring | 7 | 2022 | 254 | 0.640 |
Why?
| Oocytes | 2 | 2021 | 170 | 0.630 |
Why?
| Fluorocarbons | 1 | 2020 | 94 | 0.610 |
Why?
| Neonatal Screening | 3 | 2020 | 152 | 0.590 |
Why?
| Australia | 10 | 2022 | 206 | 0.530 |
Why?
| Cyprinidae | 1 | 2016 | 19 | 0.530 |
Why?
| Pain | 5 | 2023 | 705 | 0.520 |
Why?
| Surveys and Questionnaires | 4 | 2017 | 4620 | 0.480 |
Why?
| Pain Measurement | 3 | 2017 | 444 | 0.460 |
Why?
| Embryo, Nonmammalian | 2 | 2019 | 173 | 0.440 |
Why?
| Health Status Indicators | 1 | 2014 | 156 | 0.440 |
Why?
| Patient Outcome Assessment | 1 | 2014 | 122 | 0.430 |
Why?
| Adult | 38 | 2023 | 30528 | 0.430 |
Why?
| Tricuspid Valve Insufficiency | 3 | 2011 | 19 | 0.410 |
Why?
| Humans | 71 | 2023 | 114623 | 0.410 |
Why?
| Peptide Fragments | 4 | 2014 | 665 | 0.390 |
Why?
| Thrombosis | 4 | 2021 | 298 | 0.390 |
Why?
| Antithrombins | 2 | 2011 | 49 | 0.380 |
Why?
| Empirical Research | 1 | 2011 | 21 | 0.370 |
Why?
| Nomograms | 1 | 2011 | 41 | 0.360 |
Why?
| Male | 43 | 2021 | 55554 | 0.360 |
Why?
| Evidence-Based Medicine | 5 | 2017 | 668 | 0.350 |
Why?
| Censuses | 1 | 2010 | 18 | 0.350 |
Why?
| Hemopexin | 2 | 2021 | 13 | 0.350 |
Why?
| Female | 40 | 2021 | 59466 | 0.350 |
Why?
| Endocrine Disruptors | 3 | 2016 | 34 | 0.340 |
Why?
| Animals | 26 | 2023 | 31694 | 0.340 |
Why?
| Vitellogenins | 3 | 2016 | 10 | 0.320 |
Why?
| Health Priorities | 1 | 2009 | 34 | 0.310 |
Why?
| Thrombophilia | 3 | 2007 | 67 | 0.310 |
Why?
| Young Adult | 16 | 2021 | 10455 | 0.310 |
Why?
| Middle Aged | 24 | 2021 | 26719 | 0.300 |
Why?
| Carotid Artery, Internal, Dissection | 1 | 2008 | 6 | 0.300 |
Why?
| Stroke | 3 | 2021 | 1021 | 0.300 |
Why?
| Hospitalists | 1 | 2011 | 174 | 0.300 |
Why?
| Population Surveillance | 2 | 2010 | 392 | 0.300 |
Why?
| Self Care | 1 | 2010 | 349 | 0.300 |
Why?
| Estuaries | 2 | 2021 | 2 | 0.300 |
Why?
| Gonads | 2 | 2018 | 21 | 0.290 |
Why?
| Heart Septal Defects, Atrial | 2 | 2005 | 51 | 0.290 |
Why?
| Nitric Oxide | 2 | 2018 | 823 | 0.280 |
Why?
| Health Services Accessibility | 3 | 2016 | 761 | 0.280 |
Why?
| Sickle Cell Trait | 2 | 2018 | 14 | 0.280 |
Why?
| Biodiversity | 2 | 2021 | 349 | 0.280 |
Why?
| Fresh Water | 3 | 2020 | 48 | 0.280 |
Why?
| Haptoglobins | 2 | 2018 | 47 | 0.270 |
Why?
| Estradiol | 4 | 2016 | 455 | 0.270 |
Why?
| Kinetics | 2 | 2020 | 1551 | 0.270 |
Why?
| Insecta | 1 | 2006 | 64 | 0.270 |
Why?
| Phospholipids | 1 | 2008 | 197 | 0.270 |
Why?
| Environmental Pollutants | 2 | 2019 | 110 | 0.260 |
Why?
| Patient Education as Topic | 1 | 2010 | 680 | 0.260 |
Why?
| Pregnancy Complications, Hematologic | 1 | 2005 | 16 | 0.260 |
Why?
| Estrone | 2 | 2016 | 35 | 0.240 |
Why?
| Hospitalization | 3 | 2014 | 1749 | 0.230 |
Why?
| Mass Screening | 1 | 2011 | 1004 | 0.230 |
Why?
| Adolescent | 17 | 2021 | 17831 | 0.220 |
Why?
| beta-Thalassemia | 1 | 2023 | 23 | 0.220 |
Why?
| Cadmium | 2 | 2021 | 58 | 0.210 |
Why?
| Hemostasis | 2 | 2007 | 67 | 0.210 |
Why?
| Hemoglobinopathies | 1 | 2023 | 4 | 0.210 |
Why?
| Headache | 2 | 2023 | 132 | 0.210 |
Why?
| Wetlands | 2 | 2022 | 28 | 0.210 |
Why?
| Antisickling Agents | 2 | 2016 | 5 | 0.210 |
Why?
| Psychometrics | 3 | 2016 | 608 | 0.210 |
Why?
| Severity of Illness Index | 3 | 2021 | 2537 | 0.210 |
Why?
| Child | 19 | 2023 | 18404 | 0.210 |
Why?
| Bays | 3 | 2017 | 6 | 0.210 |
Why?
| Volatile Organic Compounds | 1 | 2023 | 45 | 0.200 |
Why?
| Pesticides | 1 | 2022 | 49 | 0.200 |
Why?
| Hemolysis | 4 | 2021 | 146 | 0.200 |
Why?
| Recombinant Proteins | 4 | 2011 | 1230 | 0.200 |
Why?
| Arginine | 2 | 2015 | 238 | 0.200 |
Why?
| Extracellular Vesicles | 1 | 2023 | 83 | 0.190 |
Why?
| Metallothionein | 1 | 2021 | 24 | 0.190 |
Why?
| Arterial Occlusive Diseases | 1 | 2021 | 74 | 0.190 |
Why?
| Acute Pain | 1 | 2021 | 35 | 0.180 |
Why?
| alpha-Thalassemia | 1 | 2020 | 4 | 0.180 |
Why?
| Desogestrel | 1 | 2021 | 40 | 0.180 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2021 | 72 | 0.180 |
Why?
| Fertility Preservation | 1 | 2021 | 46 | 0.180 |
Why?
| Purinergic P2Y Receptor Antagonists | 1 | 2021 | 62 | 0.180 |
Why?
| Aged | 10 | 2021 | 19061 | 0.180 |
Why?
| Vascular Remodeling | 2 | 2019 | 153 | 0.180 |
Why?
| Infertility, Female | 1 | 2021 | 94 | 0.170 |
Why?
| Hemorrhage | 2 | 2021 | 620 | 0.170 |
Why?
| Ecotoxicology | 1 | 2019 | 2 | 0.170 |
Why?
| Exercise Tolerance | 2 | 2011 | 213 | 0.170 |
Why?
| Partial Thromboplastin Time | 2 | 2011 | 51 | 0.170 |
Why?
| Polycyclic Aromatic Hydrocarbons | 2 | 2016 | 24 | 0.170 |
Why?
| Clove Oil | 1 | 2019 | 1 | 0.170 |
Why?
| Eugenol | 1 | 2019 | 3 | 0.170 |
Why?
| Iron Overload | 2 | 2011 | 9 | 0.170 |
Why?
| Iron Chelating Agents | 2 | 2011 | 16 | 0.170 |
Why?
| Cyprinodontiformes | 1 | 2019 | 5 | 0.160 |
Why?
| Benzoates | 2 | 2011 | 38 | 0.160 |
Why?
| Altitude | 3 | 2018 | 432 | 0.160 |
Why?
| Multiple Organ Failure | 2 | 2005 | 146 | 0.160 |
Why?
| Plastics | 1 | 2019 | 35 | 0.160 |
Why?
| Signal Transduction | 2 | 2013 | 4509 | 0.160 |
Why?
| Anesthetics | 1 | 2019 | 54 | 0.160 |
Why?
| Reproducibility of Results | 3 | 2017 | 2762 | 0.160 |
Why?
| Unrelated Donors | 1 | 2019 | 37 | 0.160 |
Why?
| Lipids | 2 | 2023 | 580 | 0.160 |
Why?
| Aspirin | 1 | 2021 | 324 | 0.150 |
Why?
| Surgical Procedures, Operative | 2 | 2014 | 207 | 0.150 |
Why?
| United States | 11 | 2023 | 12176 | 0.150 |
Why?
| Triazoles | 2 | 2011 | 131 | 0.150 |
Why?
| Venous Thromboembolism | 1 | 2021 | 231 | 0.150 |
Why?
| Europe | 2 | 2016 | 334 | 0.150 |
Why?
| Prospective Studies | 8 | 2019 | 6217 | 0.150 |
Why?
| Cohort Studies | 7 | 2018 | 4894 | 0.150 |
Why?
| Climate Change | 1 | 2019 | 120 | 0.150 |
Why?
| Bone Marrow Transplantation | 1 | 2019 | 239 | 0.150 |
Why?
| Hypoxia | 3 | 2019 | 957 | 0.150 |
Why?
| Anesthesia | 1 | 2019 | 117 | 0.140 |
Why?
| Renal Insufficiency, Chronic | 2 | 2019 | 486 | 0.140 |
Why?
| Lipoproteins | 1 | 2018 | 159 | 0.140 |
Why?
| Factor Analysis, Statistical | 2 | 2016 | 257 | 0.140 |
Why?
| Pulmonary Artery | 4 | 2019 | 1015 | 0.140 |
Why?
| Physical Exertion | 1 | 2018 | 209 | 0.140 |
Why?
| Zinc | 1 | 2020 | 260 | 0.140 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 663 | 0.140 |
Why?
| Retrospective Studies | 8 | 2021 | 12542 | 0.140 |
Why?
| Platelet Factor 4 | 2 | 2008 | 21 | 0.140 |
Why?
| Toll-Like Receptor 9 | 1 | 2017 | 30 | 0.140 |
Why?
| Graft vs Host Disease | 1 | 2019 | 212 | 0.140 |
Why?
| Macrophages | 2 | 2023 | 1261 | 0.140 |
Why?
| Carps | 1 | 2016 | 2 | 0.140 |
Why?
| Osmeriformes | 1 | 2016 | 1 | 0.130 |
Why?
| Phenylketonurias | 1 | 2016 | 11 | 0.130 |
Why?
| Asia | 1 | 2016 | 53 | 0.130 |
Why?
| Principal Component Analysis | 2 | 2016 | 175 | 0.130 |
Why?
| Heart Diseases | 1 | 2019 | 331 | 0.130 |
Why?
| Metals, Heavy | 1 | 2016 | 19 | 0.130 |
Why?
| Sewage | 1 | 2016 | 27 | 0.130 |
Why?
| Olfactory Perception | 1 | 2016 | 21 | 0.130 |
Why?
| Erythrocyte Transfusion | 2 | 2015 | 189 | 0.130 |
Why?
| Rivers | 1 | 2016 | 54 | 0.130 |
Why?
| Treatment Outcome | 5 | 2021 | 9084 | 0.130 |
Why?
| Trace Elements | 1 | 2016 | 45 | 0.130 |
Why?
| Lung Diseases | 2 | 2019 | 701 | 0.130 |
Why?
| Zebrafish | 1 | 2019 | 411 | 0.130 |
Why?
| Rivaroxaban | 1 | 2017 | 211 | 0.130 |
Why?
| Copper | 1 | 2016 | 100 | 0.130 |
Why?
| Thalassemia | 1 | 2015 | 7 | 0.130 |
Why?
| Fatigue | 1 | 2017 | 294 | 0.130 |
Why?
| North America | 1 | 2016 | 256 | 0.120 |
Why?
| Splenic Infarction | 1 | 2014 | 2 | 0.120 |
Why?
| Biomarkers | 5 | 2017 | 3408 | 0.120 |
Why?
| Protein S Deficiency | 1 | 1994 | 6 | 0.120 |
Why?
| Quality of Health Care | 2 | 2016 | 573 | 0.120 |
Why?
| Transplantation Conditioning | 1 | 2015 | 151 | 0.120 |
Why?
| Dalteparin | 1 | 2014 | 9 | 0.120 |
Why?
| Complement Inactivator Proteins | 1 | 1994 | 40 | 0.120 |
Why?
| Blood Component Removal | 1 | 2014 | 29 | 0.120 |
Why?
| Lung | 2 | 2018 | 3558 | 0.120 |
Why?
| Neoplasms | 2 | 2021 | 2097 | 0.120 |
Why?
| Patient Reported Outcome Measures | 1 | 2016 | 250 | 0.120 |
Why?
| Blood Loss, Surgical | 1 | 2014 | 84 | 0.110 |
Why?
| Postoperative Hemorrhage | 1 | 2014 | 74 | 0.110 |
Why?
| Thromboembolism | 1 | 2014 | 92 | 0.110 |
Why?
| Prevalence | 3 | 2023 | 2249 | 0.110 |
Why?
| Larva | 2 | 2019 | 194 | 0.110 |
Why?
| Infant, Newborn | 4 | 2020 | 5043 | 0.110 |
Why?
| Leg Ulcer | 1 | 2013 | 6 | 0.110 |
Why?
| Sex Factors | 3 | 2019 | 1715 | 0.110 |
Why?
| Chronic Pain | 1 | 2017 | 210 | 0.110 |
Why?
| Venous Thrombosis | 2 | 2005 | 140 | 0.110 |
Why?
| Blood Flow Velocity | 2 | 2014 | 387 | 0.110 |
Why?
| Societies, Medical | 1 | 2017 | 663 | 0.110 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2013 | 90 | 0.110 |
Why?
| Ethinyl Estradiol | 1 | 2012 | 17 | 0.110 |
Why?
| Analgesics, Opioid | 3 | 2023 | 771 | 0.110 |
Why?
| Thrombin | 2 | 2023 | 139 | 0.110 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 797 | 0.100 |
Why?
| Testosterone | 1 | 2016 | 343 | 0.100 |
Why?
| Ambulatory Care | 1 | 2016 | 478 | 0.100 |
Why?
| Preoperative Care | 2 | 2005 | 319 | 0.100 |
Why?
| Practice Guidelines as Topic | 3 | 2015 | 1394 | 0.100 |
Why?
| Endothelium, Vascular | 1 | 2018 | 843 | 0.100 |
Why?
| Mortality | 2 | 2012 | 287 | 0.100 |
Why?
| Prostheses and Implants | 2 | 2021 | 137 | 0.100 |
Why?
| Hemoglobin SC Disease | 3 | 1998 | 15 | 0.100 |
Why?
| Hydrogen-Ion Concentration | 1 | 2012 | 511 | 0.090 |
Why?
| Creatinine | 2 | 2014 | 425 | 0.090 |
Why?
| Pipecolic Acids | 1 | 2011 | 23 | 0.090 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2013 | 473 | 0.090 |
Why?
| Transfusion Reaction | 1 | 2011 | 65 | 0.090 |
Why?
| Disease Progression | 4 | 2023 | 2380 | 0.090 |
Why?
| Hemofiltration | 1 | 2010 | 31 | 0.090 |
Why?
| Sulfones | 1 | 2011 | 97 | 0.090 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 520 | 0.090 |
Why?
| Heme | 2 | 2021 | 52 | 0.090 |
Why?
| Awareness | 1 | 2010 | 93 | 0.080 |
Why?
| Disease Management | 2 | 2011 | 560 | 0.080 |
Why?
| Child, Preschool | 9 | 2017 | 9108 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 2 | 2016 | 1842 | 0.080 |
Why?
| Pregnancy | 3 | 2005 | 5517 | 0.080 |
Why?
| Vasodilator Agents | 1 | 2011 | 302 | 0.080 |
Why?
| Software | 1 | 2013 | 529 | 0.080 |
Why?
| Depression | 1 | 2017 | 1133 | 0.080 |
Why?
| Piperazines | 1 | 2011 | 309 | 0.080 |
Why?
| Career Choice | 1 | 2010 | 177 | 0.080 |
Why?
| Echocardiography | 1 | 2011 | 553 | 0.080 |
Why?
| Endothelial Cells | 1 | 2013 | 681 | 0.080 |
Why?
| Oxidation-Reduction | 3 | 2018 | 923 | 0.080 |
Why?
| Metabolomics | 1 | 2013 | 521 | 0.080 |
Why?
| Seawater | 1 | 2008 | 19 | 0.080 |
Why?
| Drug Utilization Review | 1 | 2008 | 57 | 0.080 |
Why?
| Anaerobiosis | 1 | 2008 | 49 | 0.080 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 83 | 0.080 |
Why?
| Kidney Function Tests | 1 | 2008 | 140 | 0.080 |
Why?
| Cost of Illness | 1 | 2010 | 254 | 0.070 |
Why?
| Acute Kidney Injury | 2 | 2010 | 637 | 0.070 |
Why?
| Ventricular Dysfunction, Left | 1 | 2011 | 358 | 0.070 |
Why?
| Community Participation | 1 | 2009 | 116 | 0.070 |
Why?
| Environmental Exposure | 3 | 2019 | 372 | 0.070 |
Why?
| Double-Blind Method | 3 | 2023 | 1660 | 0.070 |
Why?
| Body Size | 1 | 2008 | 91 | 0.070 |
Why?
| Registries | 2 | 2023 | 1767 | 0.070 |
Why?
| Sulfonamides | 1 | 2011 | 445 | 0.070 |
Why?
| Lipid Peroxidation | 2 | 2018 | 139 | 0.070 |
Why?
| Algorithms | 1 | 2014 | 1466 | 0.070 |
Why?
| Histocompatibility Testing | 2 | 2019 | 116 | 0.070 |
Why?
| Age Factors | 2 | 2014 | 2894 | 0.070 |
Why?
| Deferoxamine | 1 | 2007 | 18 | 0.070 |
Why?
| Social Support | 1 | 2010 | 528 | 0.070 |
Why?
| Chironomidae | 1 | 2006 | 1 | 0.070 |
Why?
| Rhabdomyolysis | 2 | 2018 | 16 | 0.070 |
Why?
| Urbanization | 2 | 2016 | 24 | 0.070 |
Why?
| Time Factors | 3 | 2019 | 6112 | 0.070 |
Why?
| Body Weight | 2 | 2021 | 868 | 0.060 |
Why?
| Sodium Chloride | 1 | 2006 | 136 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2016 | 1815 | 0.060 |
Why?
| Coronary Angiography | 1 | 2008 | 304 | 0.060 |
Why?
| Fibrinolysis | 2 | 1998 | 158 | 0.060 |
Why?
| Ecosystem | 2 | 2021 | 502 | 0.060 |
Why?
| Health Care Surveys | 2 | 2020 | 539 | 0.060 |
Why?
| Species Specificity | 1 | 2006 | 542 | 0.060 |
Why?
| Dermatan Sulfate | 1 | 2005 | 3 | 0.060 |
Why?
| Factor V | 1 | 2005 | 22 | 0.060 |
Why?
| Captopril | 1 | 2005 | 10 | 0.060 |
Why?
| Infant Mortality | 1 | 2005 | 91 | 0.060 |
Why?
| Heparitin Sulfate | 1 | 2005 | 39 | 0.060 |
Why?
| Needs Assessment | 1 | 2007 | 314 | 0.060 |
Why?
| Survival Analysis | 1 | 2008 | 1211 | 0.060 |
Why?
| Chondroitin Sulfates | 1 | 2005 | 33 | 0.060 |
Why?
| Angina, Unstable | 1 | 2005 | 72 | 0.060 |
Why?
| Polysaccharides | 1 | 2005 | 78 | 0.060 |
Why?
| Mice | 4 | 2023 | 14860 | 0.060 |
Why?
| Immunoglobulin G | 1 | 2008 | 770 | 0.060 |
Why?
| Risk | 2 | 2005 | 812 | 0.060 |
Why?
| Chest Pain | 1 | 2005 | 81 | 0.060 |
Why?
| Mice, Inbred C57BL | 3 | 2018 | 4689 | 0.060 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2005 | 64 | 0.060 |
Why?
| Follow-Up Studies | 3 | 2021 | 4411 | 0.060 |
Why?
| Practice Patterns, Physicians' | 2 | 2013 | 1177 | 0.060 |
Why?
| Risk Factors | 5 | 2018 | 8628 | 0.060 |
Why?
| Blood Component Transfusion | 1 | 2005 | 78 | 0.060 |
Why?
| Disease Models, Animal | 3 | 2019 | 3531 | 0.060 |
Why?
| Drug Combinations | 1 | 2005 | 287 | 0.060 |
Why?
| Acute Disease | 2 | 2019 | 910 | 0.060 |
Why?
| Alabama | 1 | 2023 | 28 | 0.050 |
Why?
| Oxygen | 1 | 2008 | 854 | 0.050 |
Why?
| Syndrome | 2 | 2014 | 333 | 0.050 |
Why?
| Healthcare Disparities | 1 | 2009 | 479 | 0.050 |
Why?
| Simazine | 1 | 2022 | 2 | 0.050 |
Why?
| Aged, 80 and over | 3 | 2014 | 6344 | 0.050 |
Why?
| Education, Medical, Graduate | 1 | 2007 | 368 | 0.050 |
Why?
| Renal Insufficiency | 1 | 2005 | 137 | 0.050 |
Why?
| Substance-Related Disorders | 1 | 2011 | 947 | 0.050 |
Why?
| E-Selectin | 1 | 2023 | 53 | 0.050 |
Why?
| Antibodies | 1 | 2005 | 371 | 0.050 |
Why?
| Medical Records | 1 | 2023 | 153 | 0.050 |
Why?
| Coronary Artery Disease | 1 | 2008 | 607 | 0.050 |
Why?
| United Kingdom | 2 | 2014 | 226 | 0.050 |
Why?
| Incidence | 2 | 2021 | 2311 | 0.050 |
Why?
| Agriculture | 1 | 2022 | 72 | 0.050 |
Why?
| Blood Pressure | 3 | 2018 | 1538 | 0.050 |
Why?
| P-Selectin | 1 | 2021 | 25 | 0.050 |
Why?
| Vitrification | 1 | 2021 | 6 | 0.050 |
Why?
| Oocyte Retrieval | 1 | 2021 | 11 | 0.050 |
Why?
| Dietary Exposure | 1 | 2021 | 7 | 0.050 |
Why?
| Ovarian Hyperstimulation Syndrome | 1 | 2021 | 6 | 0.050 |
Why?
| Oogenesis | 1 | 2021 | 25 | 0.050 |
Why?
| Phylogeography | 1 | 2021 | 44 | 0.050 |
Why?
| von Willebrand Factor | 2 | 1998 | 56 | 0.050 |
Why?
| Ovulation Induction | 1 | 2021 | 49 | 0.050 |
Why?
| Leukocytes, Mononuclear | 1 | 2023 | 493 | 0.050 |
Why?
| Anti-Mullerian Hormone | 1 | 2021 | 50 | 0.040 |
Why?
| Monocytes | 1 | 2023 | 502 | 0.040 |
Why?
| Multivariate Analysis | 2 | 2016 | 1430 | 0.040 |
Why?
| HIV Infections | 1 | 1994 | 2469 | 0.040 |
Why?
| Metals | 1 | 2021 | 106 | 0.040 |
Why?
| Luteinizing Hormone | 1 | 2021 | 169 | 0.040 |
Why?
| Cardiac Catheterization | 1 | 2004 | 534 | 0.040 |
Why?
| Cryopreservation | 1 | 2021 | 92 | 0.040 |
Why?
| Australasia | 1 | 2019 | 2 | 0.040 |
Why?
| Iron | 2 | 2015 | 233 | 0.040 |
Why?
| Case-Control Studies | 2 | 2018 | 3003 | 0.040 |
Why?
| Follicle Stimulating Hormone | 1 | 2021 | 216 | 0.040 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2005 | 1214 | 0.040 |
Why?
| Gonadotropin-Releasing Hormone | 1 | 2021 | 188 | 0.040 |
Why?
| Rats | 2 | 2019 | 4958 | 0.040 |
Why?
| Gadolinium | 1 | 2019 | 73 | 0.040 |
Why?
| Cell Line | 2 | 2015 | 2635 | 0.040 |
Why?
| Tissue Distribution | 1 | 2019 | 286 | 0.040 |
Why?
| Proteinuria | 1 | 2018 | 77 | 0.040 |
Why?
| Allografts | 1 | 2019 | 122 | 0.040 |
Why?
| Guinea Pigs | 1 | 2018 | 136 | 0.040 |
Why?
| Endothelins | 1 | 2018 | 61 | 0.040 |
Why?
| Thrombomodulin | 1 | 1998 | 7 | 0.040 |
Why?
| Pilot Projects | 2 | 2016 | 1372 | 0.040 |
Why?
| Body Height | 1 | 2018 | 180 | 0.040 |
Why?
| Proteomics | 1 | 2023 | 836 | 0.040 |
Why?
| Victoria | 1 | 2017 | 15 | 0.040 |
Why?
| Cross-Sectional Studies | 3 | 2016 | 4405 | 0.040 |
Why?
| Public Health Practice | 1 | 2017 | 61 | 0.040 |
Why?
| Disease-Free Survival | 1 | 2019 | 620 | 0.040 |
Why?
| Anemia, Hemolytic | 1 | 2017 | 18 | 0.040 |
Why?
| Clinical Trials as Topic | 1 | 2021 | 931 | 0.040 |
Why?
| Drug Administration Schedule | 2 | 2011 | 718 | 0.040 |
Why?
| Acclimatization | 1 | 2018 | 149 | 0.030 |
Why?
| Cytochrome P-450 CYP1A1 | 1 | 2016 | 7 | 0.030 |
Why?
| Proteins | 1 | 2023 | 908 | 0.030 |
Why?
| Fish Proteins | 1 | 2016 | 9 | 0.030 |
Why?
| Magnetic Resonance Imaging | 1 | 2008 | 3039 | 0.030 |
Why?
| Intraoperative Complications | 1 | 1998 | 122 | 0.030 |
Why?
| Bile | 1 | 2016 | 26 | 0.030 |
Why?
| Public-Private Sector Partnerships | 1 | 2017 | 43 | 0.030 |
Why?
| Polychlorinated Biphenyls | 1 | 2016 | 7 | 0.030 |
Why?
| Blood Coagulation Factors | 1 | 1996 | 44 | 0.030 |
Why?
| RNA, Messenger | 2 | 2013 | 2552 | 0.030 |
Why?
| Genetic Markers | 1 | 2017 | 320 | 0.030 |
Why?
| United States Food and Drug Administration | 1 | 2017 | 172 | 0.030 |
Why?
| Community Health Services | 1 | 2017 | 212 | 0.030 |
Why?
| Silicon Dioxide | 1 | 2016 | 88 | 0.030 |
Why?
| Mononuclear Phagocyte System | 1 | 1995 | 12 | 0.030 |
Why?
| Erythrocyte Count | 1 | 1995 | 19 | 0.030 |
Why?
| Erythrocytes, Abnormal | 1 | 1995 | 12 | 0.030 |
Why?
| Continuity of Patient Care | 1 | 2017 | 253 | 0.030 |
Why?
| Odorants | 1 | 2016 | 128 | 0.030 |
Why?
| Arginase | 1 | 2015 | 27 | 0.030 |
Why?
| Blood Platelets | 1 | 1998 | 351 | 0.030 |
Why?
| Vitamin B 6 Deficiency | 1 | 1994 | 5 | 0.030 |
Why?
| Excitatory Amino Acids | 1 | 1994 | 7 | 0.030 |
Why?
| Survival Rate | 1 | 2019 | 1644 | 0.030 |
Why?
| Amino Acids, Sulfur | 1 | 1994 | 8 | 0.030 |
Why?
| Blood Coagulation | 1 | 1996 | 218 | 0.030 |
Why?
| Liver | 2 | 2016 | 1634 | 0.030 |
Why?
| Cysteic Acid | 1 | 1994 | 1 | 0.030 |
Why?
| beta 2-Glycoprotein I | 1 | 1994 | 3 | 0.030 |
Why?
| Antibodies, Anticardiolipin | 1 | 1994 | 5 | 0.030 |
Why?
| Lupus Coagulation Inhibitor | 1 | 1994 | 5 | 0.030 |
Why?
| Blood Cell Count | 1 | 2014 | 50 | 0.030 |
Why?
| Echocardiography, Doppler | 1 | 2015 | 91 | 0.030 |
Why?
| Consensus Development Conferences as Topic | 1 | 2014 | 28 | 0.030 |
Why?
| Siblings | 1 | 2015 | 221 | 0.030 |
Why?
| Health Policy | 1 | 2017 | 334 | 0.030 |
Why?
| Hematocrit | 1 | 2014 | 87 | 0.030 |
Why?
| Automation | 1 | 2014 | 73 | 0.030 |
Why?
| Penicillins | 1 | 2014 | 52 | 0.030 |
Why?
| Interview, Psychological | 1 | 2014 | 86 | 0.030 |
Why?
| Folic Acid Deficiency | 1 | 1994 | 48 | 0.030 |
Why?
| Ferritins | 1 | 2014 | 52 | 0.030 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 154 | 0.030 |
Why?
| Hypertrophy, Right Ventricular | 1 | 2015 | 141 | 0.030 |
Why?
| Vitamin B 12 Deficiency | 1 | 1994 | 74 | 0.030 |
Why?
| DNA Damage | 1 | 2016 | 351 | 0.030 |
Why?
| Muscle, Smooth, Vascular | 1 | 2017 | 411 | 0.030 |
Why?
| Hematologic Tests | 1 | 1994 | 22 | 0.030 |
Why?
| Natriuretic Peptide, Brain | 1 | 2014 | 94 | 0.030 |
Why?
| Homocysteine | 1 | 1994 | 136 | 0.030 |
Why?
| Folic Acid | 1 | 1995 | 161 | 0.030 |
Why?
| Smegmamorpha | 1 | 2013 | 2 | 0.030 |
Why?
| Carrier Proteins | 2 | 1995 | 695 | 0.030 |
Why?
| Mood Disorders | 1 | 2014 | 112 | 0.030 |
Why?
| Antibiotic Prophylaxis | 1 | 2014 | 96 | 0.030 |
Why?
| Vascular Resistance | 1 | 2015 | 337 | 0.030 |
Why?
| Abdominal Pain | 1 | 2014 | 135 | 0.030 |
Why?
| Catalase | 1 | 2013 | 118 | 0.030 |
Why?
| Liver Failure, Acute | 1 | 1994 | 58 | 0.030 |
Why?
| Perioperative Care | 1 | 2014 | 127 | 0.030 |
Why?
| Cell Membrane Permeability | 1 | 2013 | 83 | 0.030 |
Why?
| Hemoglobin, Sickle | 1 | 2013 | 14 | 0.030 |
Why?
| Cysteine | 1 | 1994 | 171 | 0.030 |
Why?
| Brain Diseases | 1 | 1994 | 124 | 0.030 |
Why?
| Permeability | 1 | 2013 | 149 | 0.030 |
Why?
| Spleen | 1 | 1995 | 487 | 0.030 |
Why?
| Employment | 1 | 2014 | 137 | 0.030 |
Why?
| Clinical Protocols | 1 | 2014 | 233 | 0.030 |
Why?
| Interleukin-6 | 1 | 2017 | 676 | 0.030 |
Why?
| Behavior, Animal | 1 | 2016 | 458 | 0.030 |
Why?
| Receptors, Cell Surface | 1 | 1995 | 355 | 0.030 |
Why?
| Methylamines | 1 | 2013 | 30 | 0.030 |
Why?
| Erythrocyte Indices | 1 | 2012 | 27 | 0.030 |
Why?
| Equipment Design | 1 | 2014 | 508 | 0.030 |
Why?
| Glycoproteins | 1 | 1994 | 304 | 0.030 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2008 | 3244 | 0.030 |
Why?
| Inflammation | 1 | 2023 | 2477 | 0.030 |
Why?
| Choline | 1 | 2013 | 106 | 0.030 |
Why?
| Vascular Diseases | 1 | 2015 | 230 | 0.020 |
Why?
| Physician-Patient Relations | 1 | 2016 | 462 | 0.020 |
Why?
| Social Behavior | 1 | 2014 | 267 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2014 | 811 | 0.020 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 249 | 0.020 |
Why?
| Public Health | 1 | 2016 | 433 | 0.020 |
Why?
| Macrophages, Alveolar | 1 | 2015 | 347 | 0.020 |
Why?
| Superoxide Dismutase | 1 | 2013 | 305 | 0.020 |
Why?
| Cell-Derived Microparticles | 1 | 2012 | 57 | 0.020 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 225 | 0.020 |
Why?
| Health Status | 1 | 2016 | 722 | 0.020 |
Why?
| Physical Therapy Modalities | 1 | 2014 | 264 | 0.020 |
Why?
| Proportional Hazards Models | 1 | 2014 | 1075 | 0.020 |
Why?
| Sildenafil Citrate | 1 | 2011 | 57 | 0.020 |
Why?
| Wounds and Injuries | 1 | 2018 | 745 | 0.020 |
Why?
| Homozygote | 1 | 2011 | 187 | 0.020 |
Why?
| Toll-Like Receptor 4 | 1 | 2013 | 287 | 0.020 |
Why?
| Hemodynamics | 2 | 2011 | 1012 | 0.020 |
Why?
| Communication | 1 | 2016 | 744 | 0.020 |
Why?
| Familial Primary Pulmonary Hypertension | 1 | 2011 | 190 | 0.020 |
Why?
| Mice, Knockout | 1 | 2017 | 2565 | 0.020 |
Why?
| Up-Regulation | 1 | 2013 | 807 | 0.020 |
Why?
| Walking | 1 | 2014 | 422 | 0.020 |
Why?
| Respiratory Insufficiency | 1 | 1994 | 290 | 0.020 |
Why?
| Metabolome | 1 | 2013 | 282 | 0.020 |
Why?
| Purines | 1 | 2011 | 159 | 0.020 |
Why?
| Erythrocytes | 1 | 1995 | 591 | 0.020 |
Why?
| Pediatrics | 1 | 2017 | 979 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2015 | 2218 | 0.020 |
Why?
| Databases, Factual | 1 | 2014 | 1124 | 0.020 |
Why?
| Cell Proliferation | 1 | 2017 | 2186 | 0.020 |
Why?
| NF-kappa B | 1 | 2013 | 638 | 0.020 |
Why?
| Pneumonia | 1 | 2015 | 567 | 0.020 |
Why?
| Sepsis | 1 | 1995 | 509 | 0.020 |
Why?
| Gastrointestinal Diseases | 1 | 2011 | 182 | 0.020 |
Why?
| Exercise Test | 1 | 2011 | 544 | 0.020 |
Why?
| Colorado | 2 | 2014 | 4099 | 0.020 |
Why?
| Gene Expression | 1 | 2013 | 1421 | 0.020 |
Why?
| Infant | 3 | 2014 | 7959 | 0.020 |
Why?
| Genotype | 1 | 2013 | 1760 | 0.020 |
Why?
| Postoperative Complications | 1 | 2018 | 2128 | 0.020 |
Why?
| Comorbidity | 1 | 2012 | 1448 | 0.020 |
Why?
| Health Personnel | 1 | 2013 | 574 | 0.020 |
Why?
| Cardiovascular Diseases | 1 | 2018 | 1727 | 0.020 |
Why?
| Chelation Therapy | 1 | 2007 | 9 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2016 | 1472 | 0.020 |
Why?
| Mental Disorders | 1 | 1994 | 892 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2011 | 1796 | 0.020 |
Why?
| Diabetic Angiopathies | 1 | 2008 | 244 | 0.020 |
Why?
| Alanine Transaminase | 1 | 2007 | 141 | 0.020 |
Why?
| Calcinosis | 1 | 2008 | 242 | 0.020 |
Why?
| Health Services | 1 | 2007 | 103 | 0.020 |
Why?
| Models, Biological | 1 | 2013 | 1620 | 0.020 |
Why?
| Critical Illness | 1 | 2010 | 644 | 0.020 |
Why?
| Program Development | 1 | 2007 | 341 | 0.010 |
Why?
| Administration, Oral | 1 | 2007 | 728 | 0.010 |
Why?
| Gas Chromatography-Mass Spectrometry | 2 | 1995 | 124 | 0.010 |
Why?
| Isotope Labeling | 2 | 1995 | 69 | 0.010 |
Why?
| Academic Medical Centers | 1 | 2007 | 410 | 0.010 |
Why?
| Logistic Models | 1 | 2008 | 1840 | 0.010 |
Why?
| Respiratory Tract Infections | 1 | 2007 | 319 | 0.010 |
Why?
| Referral and Consultation | 1 | 2007 | 632 | 0.010 |
Why?
| Attitude of Health Personnel | 1 | 2008 | 975 | 0.010 |
Why?
| Insulin Resistance | 1 | 2008 | 1072 | 0.010 |
Why?
| Physicians | 1 | 2008 | 772 | 0.010 |
Why?
| Delivery of Health Care | 1 | 2007 | 833 | 0.010 |
Why?
| Liver Function Tests | 1 | 1996 | 103 | 0.010 |
Why?
| Respiration | 1 | 1996 | 179 | 0.010 |
Why?
| Vacuoles | 1 | 1995 | 33 | 0.010 |
Why?
| Folate Receptors, GPI-Anchored | 1 | 1995 | 5 | 0.010 |
Why?
| 4-Aminobenzoic Acid | 1 | 1995 | 6 | 0.010 |
Why?
| Lactobacillus | 1 | 1995 | 24 | 0.010 |
Why?
| Radionuclide Imaging | 1 | 1995 | 115 | 0.010 |
Why?
| Carbon Isotopes | 1 | 1995 | 111 | 0.010 |
Why?
| Reference Standards | 1 | 1995 | 159 | 0.010 |
Why?
| Aspartic Acid | 1 | 1994 | 77 | 0.010 |
Why?
| Neurotransmitter Agents | 1 | 1994 | 75 | 0.010 |
Why?
| Deuterium | 1 | 1994 | 79 | 0.010 |
Why?
| Disease Susceptibility | 1 | 1995 | 316 | 0.010 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 1994 | 180 | 0.010 |
Why?
| Reference Values | 1 | 1994 | 742 | 0.010 |
Why?
| Cattle | 1 | 1995 | 920 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 1995 | 1691 | 0.010 |
Why?
| Brain | 1 | 1994 | 2371 | 0.000 |
Why?
|
|
Hassell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|